James Bradner
Chief Tech/Sci/R&D Officer bei AMGEN INC.
Vermögen: 6 Mio $ am 31.03.2024
Profil
James E.
Bradner is the founder of Tensha Therapeutics, Inc. (2011), Acetylon Pharmaceuticals, Inc. (2008), C4 Therapeutics, Inc. (2015), TetraLogic Research & Development Corp.
(2008), and Syros Pharmaceuticals, Inc. (2011).
He is currently the Chairman at Novartis Institute for Functional Genomics, Inc., Director at Foundation for the National Institutes of Health, Inc. (starting in 2023), Chief Scientific Officer at Amgen, Inc. (starting in 2023), Associate Professor at Harvard Medical School, and Advisor at Longwood Fund Management LLC.
His former positions include Associate Director-Therapeutics Science Centre at The Broad Institute, Inc., Member-Supervisory Board at QIAGEN NV (2015), Member at American Chemical Society, Member at American Society of Hematology, and President at Novartis Institutes for Biomedical Research, Inc. (2016-2022).
Dr. Bradner received his undergraduate degree from Harvard University in 1994 and his doctorate from Pritzker School of Medicine.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
AMGEN INC.
0,00% | 09.02.2024 | 22 393 ( 0,00% ) | 6 Mio $ | 31.03.2024 |
Aktive Positionen von James Bradner
| Unternehmen | Position | Beginn |
|---|---|---|
| AMGEN INC. | Chief Tech/Sci/R&D Officer | 18.12.2023 |
| Harvard Medical School | Corporate Officer/Principal | - |
Longwood Fund Management LLC
 Longwood Fund Management LLC Investment ManagersFinance Longwood Fund Management LLC (Longwood Fund Management) is a venture capital firm founded in 2010 by Christoph H. Westphal, Michelle Dipp and Richard H. Aldrich. The firm is headquartered in Boston, Massachusetts. | Consultant / Advisor | - |
Foundation for the National Institutes of Health, Inc.
 Foundation for the National Institutes of Health, Inc. Miscellaneous Commercial ServicesCommercial Services Foundation for the National Institutes of Health, Inc. provides healthcare services. It offers services to public health through scientific discovery, translational research and dissemination of research results through public-private partnerships. The organization was founded in 1996 and is headquartered in Bethesda, MD | Director/Board Member | 22.05.2023 |
Novartis Institute for Functional Genomics, Inc.
 Novartis Institute for Functional Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institute For Functional Genomics, Inc. serves as a bridge between basic science and preclinical drug discovery for Novartis’ global research organization. Its focus areas include oncology, autoimmunity, cardiovascular disease, diabetes, musculoskeletal disorders, and infectious disease. The company was founded in 1999 and is headquartered in San Diego, CA. | Chairman | - |
Ehemalige bekannte Positionen von James Bradner
| Unternehmen | Position | Ende |
|---|---|---|
Novartis Institutes for Biomedical Research, Inc.
 Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | President | 31.10.2022 |
| QIAGEN N.V. | Director/Board Member | 31.12.2015 |
| SYROS PHARMACEUTICALS, INC. | Founder | 25.10.2015 |
Tensha Therapeutics, Inc.
 Tensha Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tensha Therapeutics, Inc. develops small molecule bromodomain inhibitors. The firm’s product is used to treat cancer and other serious disorders. The company was founded by James Bradner in 2011 and is headquartered in Cambridge, MA. | Founder | - |
| ░░░░░░░░ ░░░░░░░ ░░ ░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Ausbildung von James Bradner
| Harvard University | Undergraduate Degree |
| Pritzker School of Medicine | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| AMGEN INC. | Health Technology |
| QIAGEN N.V. | Health Technology |
| SYROS PHARMACEUTICALS, INC. | Health Technology |
| C4 THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 10 |
|---|---|
Tensha Therapeutics, Inc.
Tensha Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tensha Therapeutics, Inc. develops small molecule bromodomain inhibitors. The firm’s product is used to treat cancer and other serious disorders. The company was founded by James Bradner in 2011 and is headquartered in Cambridge, MA. | Health Technology |
American Chemical Society
 American Chemical Society Miscellaneous Commercial ServicesCommercial Services American Chemical Society engages as a scientific society which supports scientific inquiry in the field of chemistry. The company was founded in 1876 and is headquartered in Washington, DC. | Commercial Services |
American Society of Hematology
 American Society of Hematology Miscellaneous Commercial ServicesCommercial Services American Society of Hematology provides the most current practice tools, clinical support and educational products needed in hematology. The firm offers educational products and services for clinicians and scientists. The company is headquartered in Washington, DC. | Commercial Services |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Commercial Services |
Foundation for the National Institutes of Health, Inc.
Foundation for the National Institutes of Health, Inc. Miscellaneous Commercial ServicesCommercial Services Foundation for the National Institutes of Health, Inc. provides healthcare services. It offers services to public health through scientific discovery, translational research and dissemination of research results through public-private partnerships. The organization was founded in 1996 and is headquartered in Bethesda, MD | Commercial Services |
Novartis Institute for Functional Genomics, Inc.
Novartis Institute for Functional Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institute For Functional Genomics, Inc. serves as a bridge between basic science and preclinical drug discovery for Novartis’ global research organization. Its focus areas include oncology, autoimmunity, cardiovascular disease, diabetes, musculoskeletal disorders, and infectious disease. The company was founded in 1999 and is headquartered in San Diego, CA. | Commercial Services |
The Broad Institute, Inc.
 The Broad Institute, Inc. BiotechnologyHealth Technology The Broad Institute, Inc. engages in the provision of research and development in biomedicals to cure infectious disease. Its scientific areas include chemical biology and therapeutics, genome regulation, cellular circuity and epigenomics, medical and population genetics, and metabolism. The company was founded by Eric S. Lander, Eli Broad and Edythe Broad in 2003 and is headquartered in Cambridge, MA. | Health Technology |
Acetylon Pharmaceuticals, Inc.
 Acetylon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Acetylon Pharmaceuticals, Inc. develops pharmaceutical technology. It develops novel small molecule drugs which targets epigenetic mechanisms for the enhancement of therapeutic outcomes in cancer and other critical human diseases. The company was founded by Ralph Mazitschek, Kenneth C. Anderson, Marc A. Cohen, James E. Bradner, and Walter C. Ogier in October 2008 and is headquartered in Boston, MA. | Health Technology |
Longwood Fund Management LLC
Longwood Fund Management LLC Investment ManagersFinance Longwood Fund Management LLC (Longwood Fund Management) is a venture capital firm founded in 2010 by Christoph H. Westphal, Michelle Dipp and Richard H. Aldrich. The firm is headquartered in Boston, Massachusetts. | Finance |
TetraLogic Research & Development Corp.
 TetraLogic Research & Development Corp. BiotechnologyHealth Technology TetraLogic Research & Development Corp. develops SHP-141 topical HDAC inhibitor clinical development for cutaneous T cell lymphoma. Its currently conducting a randomized, double-blind, placebo controlled, phase 1b study, to evaluate the safety and tolerability of SHP-141 in patients with stage 1A, 1B or 2A CTCL. The company was founded by James E. Bradner and Ralph Mazitschek in 2008 and is headquartered in Cambridge, MA. | Health Technology |
